Literature DB >> 30810594

Inflammatory markers are beneficial in the early stages of cerebral venous thrombosis.

Aysel Tekesin1, Abdulkadir Tunç2.   

Abstract

BACKGROUND: Cerebral vein thrombosis (CVT) is a rare but serious cause of acute stroke. Inflammation is a hypothetical etiological factor in CVT.
OBJECTIVE: The aim of this study was to evaluate inflammatory marker levels in CVT patients and compare these with healthy individuals.
METHODS: This prospective case-control study was conducted with 36 newly-diagnosed CVT patients age- and sex-matched with 40 healthy individuals. The laboratory investigations included a serum hemogram, full biochemistry profiles, high sensitivity C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-HDL cholesterol ratio (MHR) values were calculated and compared between the patients and healthy participants.
RESULTS: The mean age was 41.4 ± 11.8 years for patients, and 39.3 ± 12.5 for controls. Lymphocyte, total bilirubin, indirect bilirubin, and HDL levels were significantly lower in CVT patients (p < 0.05), while CRP, and ESR values were significantly higher. In the CVT patients the mean NLR and PLR values were significantly higher than in the control individuals. Smoking rates, alcohol consumption, white blood cell, neutrophil, platelet, and MHR values were similar in both groups (p 0.05).
CONCLUSIONS: We suggest that NLR, PLR, CRP, ESR, and bilirubin can be used in clinical practice for prediction of CVT in suspected patients as they are inexpensive parameters and widely available. However, further large-scale studies are required to confirm this relationship.

Entities:  

Year:  2019        PMID: 30810594     DOI: 10.1590/0004-282X20190001

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  5 in total

1.  Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms Associated with Cardiovascular Risk Factors Involved in Cerebral Venous Sinus Thrombosis.

Authors:  Anca Elena Gogu; Andrei Gheorghe Motoc; Alina Zorina Stroe; Any Docu Axelerad; Daniel Docu Axelerad; Ligia Petrica; Dragos Catalin Jianu
Journal:  Metabolites       Date:  2021-04-23

Review 2.  Inflammation in Cerebral Venous Thrombosis.

Authors:  Jiayue Ding; Baoying Song; Xiran Xie; Xaingyu Li; Zhiying Chen; Zhongao Wang; Liqun Pan; Duo Lan; Ran Meng
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

3.  Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis.

Authors:  Zhen Ye; Tingyi Hu; Jin Wang; Ruoyi Xiao; Xibei Liao; Mengsi Liu; Zhen Sun
Journal:  Front Cardiovasc Med       Date:  2022-08-08

Review 4.  Inflammation and Severe Cerebral Venous Thrombosis.

Authors:  Shuyuan Hu; Hangil Lee; Haiping Zhao; Yuchuan Ding; Jiangang Duan
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

5.  A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis.

Authors:  Yueyi Xing; Zibin Tian; Yueping Jiang; Ge Guan; Qinghui Niu; Xueguo Sun; Rongshuang Han; Xue Jing
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.